CD248: reviewing its role in health and disease.

Curr Drug Targets

Division of Hematology, Department of Medicine, Centre for Blood Research, University of British Columbia, Vancouver, British Columbia, Canada.

Published: March 2012

CD248, also known as endosialin or tumor endothelial marker-1 (TEM-1), is a C-type lectin-like domain (CTLD) containing cell surface glycoprotein that is expressed by stromal cells of proliferating tissues during embryogenesis and postnatally in tumors and inflammatory lesions. Loss-of-function studies in mice support the notion that CD248 promotes tumor growth and inflammation, observations that are stimulating interest in evaluating this molecule as a therapeutic target. In spite of these advances, the mechanisms by which CD248 modulates cancer and inflammation remain largely enigmatic. This review highlights our current understanding of CD248, its structure, pattern of expression, regulation and function in various disease processes.

Download full-text PDF

Source
http://dx.doi.org/10.2174/138945012799424615DOI Listing

Publication Analysis

Top Keywords

cd248
5
cd248 reviewing
4
reviewing role
4
role health
4
health disease
4
disease cd248
4
cd248 endosialin
4
endosialin tumor
4
tumor endothelial
4
endothelial marker-1
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!